Keralam Health department introduces district-level system to monitor medicine stocks

The Kerala Health department has implemented a district-level system to monitor the availability of essential medicines in government hospitals. Health Minister K. Muraleedharan issued instructions to the Principal Secretary (Health) to establish a district-level medicine availability monitoring team in each district. The teams will be led by the Additional District Medical Officer (Health) or Deputy DMO (Health) and will consist of hospital superintendents, assistant drugs controllers or drug inspectors, pharmacy store superintendents, and the warehouse manager from the Kerala Medical Services Corporation Limited (KMSCL).

The primary objective of this new mechanism is to anticipate and address potential medicine shortages before they escalate. The teams will evaluate hospital stocks, patient numbers, medicine consumption rates, projected needs, and potential supply delays. They will conduct on-site inspections of hospital pharmacies and stores, going beyond reliance on records.

Even if records suggest sufficient supplies, the teams will verify the adequacy of pharmacy stocks, potential supply delays, and the duration the existing stock would last.

These teams will also explore the possibility of reallocating medicines between hospitals when one facility has surplus quantities of specific medicines while another encounters shortages. This reallocation would optimize the utilization of available medicines during emergencies, preventing reliance solely on future supply arrivals.

Weekly reports will be prepared by the district-level teams, covering hospitals up to district general hospitals and submitted to the Director of Health Services. Reports concerning medical colleges will be submitted to the Director of Medical Education. The weekly reports will encompass details of medicines available at each hospital, medicines in short supply, requirements based on patient numbers, anticipated needs for upcoming periods, reasons for shortages, information on medicines procured through KMSCL, and corrective measures already implemented.